Bio-Works Technologies AB (publ)
Stockholm Stock ExchangeTotal Valuation
Bio-Works Technologies AB (publ) carries a market capitalization of 264.91M, placing it among publicly traded companies globally.
| Market Cap | 264.91M |
| Enterprise Value | N/A |
Share Statistics
Bio-Works Technologies AB (publ) currently has 99.42M shares outstanding.
| Shares Outstanding | 99.42M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 3.93, and the price-to-book ratio stands at 32.76.
| PE Ratio | N/A |
| PS Ratio | 3.93 |
| PB Ratio | 32.76 |
| P/TBV Ratio | 5.92 |
| P/FCF Ratio | -40.36 |
| P/OCF Ratio | -35.80 |
Financial Position
Bio-Works Technologies AB (publ) maintains a current ratio of 4.44, meaning it holds 4.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.44 |
| Quick Ratio | 2.66 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -43.05 |
Financial Efficiency
| Return on Equity (ROE) | -28.86 |
| Return on Assets (ROA) | -4.21 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -27.10 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.44 |
Taxes
Over the trailing twelve months, Bio-Works Technologies AB (publ) has paid -1.90M in income taxes, reflecting an effective tax rate of 0.49.
| Income Tax | -1.90M |
| Effective Tax Rate | 0.49 |
Stock Price Statistics
Bio-Works Technologies AB (publ)'s stock has gained approximately 96.31902% over the past 52 weeks. The 50-day moving average sits at 3.56, while the 200-day moving average is 2.97.
| Beta (5Y) | N/A |
| 52-Week Price Change | 96.31902% |
| 50-Day Moving Average | 3.56 |
| 200-Day Moving Average | 2.97 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Bio-Works Technologies AB (publ) generated 82.85M in revenue and converted that into -2.59M in net income, yielding earnings per share of -0.03. EBITDA reached -5.51M, while operating income came in at -5.51M.
| Revenue | 82.85M |
| Gross Profit | 62.14M |
| Operating Income | -5.51M |
| Pretax Income | -4.50M |
| Net Income | -2.59M |
| EBITDA | -5.51M |
| EBIT | -5.51M |
| Earnings Per Share (EPS) | -0.03 |
Balance Sheet
Total book value stands at 9.94M, with working capital of 53.33M providing operational flexibility.
| Cash & Cash Equivalents | 41.26M |
| Total Debt | N/A |
| Net Debt | -41.26M |
| Equity (Book Value) | 9.94M |
| Book Value Per Share | 0.11 |
| Working Capital | 53.33M |
Cash Flow
Bio-Works Technologies AB (publ) produced -9.10M in operating cash flow over the past twelve months. After subtracting -507,000.00 in capital expenditures, free cash flow totaled -9.60M - equivalent to -0.11 per share.
| Operating Cash Flow | -9.10M |
| Capital Expenditures | -507,000.00 |
| Free Cash Flow | -9.60M |
| FCF Per Share | -0.11 |
Margins
Bio-Works Technologies AB (publ) operates with a gross margin of 75.00, reflecting its pricing power and cost economics. The operating margin of -6.65 and net profit margin of -3.13 provide insight into operational efficiency.
| Gross Margin | 75.00 |
| Operating Margin | -6.65 |
| Pretax Margin | -5.43 |
| Profit Margin | -3.13 |
| EBITDA Margin | -6.65 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -6.51 |
| FCF Yield | -2.48 |
Stock Splits
Bio-Works Technologies AB (publ)'s most recent stock split took place on June 3, 2019 with a 250:259 split ratio.
| Last Split Date | 6/3/2019 |
| Split Ratio | 250:259 |
Scores
Bio-Works Technologies AB (publ) posts an Altman Z-Score of 14.41, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 14.41 |